FR2996847B1 - Composes 3,4-bis(catechol)pyrrole-n-substitues, leur preparation et utilisation dans le traitement du cancer - Google Patents

Composes 3,4-bis(catechol)pyrrole-n-substitues, leur preparation et utilisation dans le traitement du cancer

Info

Publication number
FR2996847B1
FR2996847B1 FR1259868A FR1259868A FR2996847B1 FR 2996847 B1 FR2996847 B1 FR 2996847B1 FR 1259868 A FR1259868 A FR 1259868A FR 1259868 A FR1259868 A FR 1259868A FR 2996847 B1 FR2996847 B1 FR 2996847B1
Authority
FR
France
Prior art keywords
catechol
pyrrole
cancer
bis
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1259868A
Other languages
English (en)
French (fr)
Other versions
FR2996847A1 (fr
Inventor
Pascal Collin
Maxim Egorov
Bernard Delpech
Joanna Bakala
Maria Achab
Jerome Bignon
Odile Thoison
Michel Benechie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR1259868A priority Critical patent/FR2996847B1/fr
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Priority to AU2013331764A priority patent/AU2013331764B2/en
Priority to PCT/EP2013/071445 priority patent/WO2014060366A1/fr
Priority to JP2015537212A priority patent/JP6423349B2/ja
Priority to EP13779187.7A priority patent/EP2909171B1/fr
Priority to ES13779187.7T priority patent/ES2608781T3/es
Priority to CA2888379A priority patent/CA2888379A1/fr
Priority to US14/435,768 priority patent/US9546159B2/en
Publication of FR2996847A1 publication Critical patent/FR2996847A1/fr
Application granted granted Critical
Publication of FR2996847B1 publication Critical patent/FR2996847B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/333—Radicals substituted by oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR1259868A 2012-10-16 2012-10-16 Composes 3,4-bis(catechol)pyrrole-n-substitues, leur preparation et utilisation dans le traitement du cancer Expired - Fee Related FR2996847B1 (fr)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FR1259868A FR2996847B1 (fr) 2012-10-16 2012-10-16 Composes 3,4-bis(catechol)pyrrole-n-substitues, leur preparation et utilisation dans le traitement du cancer
PCT/EP2013/071445 WO2014060366A1 (fr) 2012-10-16 2013-10-14 Composes 3,4-bis(catechol)pyrrole-n-substitues, leur preparation et utilisation dans le traitement du cancer
JP2015537212A JP6423349B2 (ja) 2012-10-16 2013-10-14 Ｎ−置換３，４−ビス（カテコール）ピロール化合物、その調製、及びガンの治療のためのその使用
EP13779187.7A EP2909171B1 (fr) 2012-10-16 2013-10-14 Composés 3,4-bis(catéchol)pyrrole n-substitués, leur préparation et utilisation dans le traitement du cancer
AU2013331764A AU2013331764B2 (en) 2012-10-16 2013-10-14 N-substituted 3,4-bis (catechol) pyrrole compounds, and the preparation and use thereof in the treatment of cancer
ES13779187.7T ES2608781T3 (es) 2012-10-16 2013-10-14 Compuestos 3,4-bis(catecol)pirrol-N-sustituidos, su preparación y su utilización en el tratamiento del cáncer
CA2888379A CA2888379A1 (fr) 2012-10-16 2013-10-14 Composes 3,4-bis(catechol)pyrrole-n-substitues, leur preparation et utilisation dans le traitement du cancer
US14/435,768 US9546159B2 (en) 2012-10-16 2013-10-14 N-substituted 3,4-bis (catechol) pyrrole compounds, and the preparation and use thereof in the treatment of cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1259868A FR2996847B1 (fr) 2012-10-16 2012-10-16 Composes 3,4-bis(catechol)pyrrole-n-substitues, leur preparation et utilisation dans le traitement du cancer

Publications (2)

Publication Number Publication Date
FR2996847A1 FR2996847A1 (fr) 2014-04-18
FR2996847B1 true FR2996847B1 (fr) 2014-12-05

Family

ID=47425104

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1259868A Expired - Fee Related FR2996847B1 (fr) 2012-10-16 2012-10-16 Composes 3,4-bis(catechol)pyrrole-n-substitues, leur preparation et utilisation dans le traitement du cancer

Country Status (8)

Country Link
US (1) US9546159B2 (https=)
EP (1) EP2909171B1 (https=)
JP (1) JP6423349B2 (https=)
AU (1) AU2013331764B2 (https=)
CA (1) CA2888379A1 (https=)
ES (1) ES2608781T3 (https=)
FR (1) FR2996847B1 (https=)
WO (1) WO2014060366A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3022244B1 (fr) * 2014-06-17 2016-07-01 Centre Nat De La Rech Scient (Cnrs) Utilisation d'un nouveau compose 3-aryl-4-catechol-pyrrole-n-propanol et ses derives pour le traitement du cancer et des pathologies associees a une angiogenese excessive
CN121154883A (zh) * 2020-05-25 2025-12-19 医工瑞思(福建)工程研究中心有限公司 一种大面积创伤急救敷料套件及其使用方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993019045A1 (en) * 1992-03-26 1993-09-30 E.I. Du Pont De Nemours And Company Arthropodicidal amides
DE19756261A1 (de) * 1997-12-17 1999-07-01 Klinge Co Chem Pharm Fab Neue arylsubstituierte Pyridylalkan-, alken- und alkincarbonsäureamide
GB9821975D0 (en) * 1998-10-08 1998-12-02 Pharma Mar Sa New cytotoxic alkaloids
WO2008064317A1 (en) * 2006-11-22 2008-05-29 University Of Medicine And Dentistry Of New Jersey Lipophilic opioid receptor active compounds
WO2008064318A2 (en) * 2006-11-22 2008-05-29 University Of Medicine And Dentistry Of New Jersey Peripheral opioid receptor active compounds

Also Published As

Publication number Publication date
CA2888379A1 (fr) 2014-04-24
JP2015534958A (ja) 2015-12-07
ES2608781T3 (es) 2017-04-17
JP6423349B2 (ja) 2018-11-14
AU2013331764B2 (en) 2017-11-16
EP2909171A1 (fr) 2015-08-26
WO2014060366A1 (fr) 2014-04-24
FR2996847A1 (fr) 2014-04-18
AU2013331764A1 (en) 2015-05-21
US9546159B2 (en) 2017-01-17
EP2909171B1 (fr) 2016-09-28
US20150344460A1 (en) 2015-12-03

Similar Documents

Publication Publication Date Title
IL253225B (en) Sulfamoyl-arylamides and their use as drugs to treat jaundice b
MA39960A (fr) Composés imidazo[4,5c]quinoline-2-one et leur utilisation dans le traitement du cancer
IL235923A0 (en) Aminotriazolopyridine for use in the treatment of inflammation, and pharmaceutical preparations thereof
SG11201602070TA (en) Substituted nicotinimide inhibitors of btk and their preparation and use in the treatment of cancer, inflammation and autoimmune disease
IL231536A (en) Indazole-3-carboxamides, pharmaceuticals containing them and their use in the treatment of diseases
PT3932932T (pt) Esteroides neuroativos e métodos para o seu uso
EP2968303A4 (en) OCTAHYDROCYCLOPENTAPYROLE AND THEIR PREPARATION AND USE
EP2830661A4 (en) DIAGNOSTIC METHOD AND COMPOSITIONS FOR CANCER TREATMENT
PL2830654T3 (pl) Sposoby i kompozycje do leczenia zapalenia
IL238800B (en) Immunomodulatory compounds and drugs containing them for use in the treatment of allergic diseases and other inflammatory conditions, infectious diseases and cancer
PL2922576T3 (pl) Sposoby podawania i oceny leków wychwytujących azot do leczenia encefalopati wątrobowej
EP2800579A4 (en) METHOD AND COMPOSITIONS FOR TREATING DIABETES
GB201222455D0 (en) Novel pharmaceutical formulations and their use in the treatment of periodontaldisease
IL233875A (en) Composition and use thereof in the treatment of anal rhagades
EP2744786A4 (en) SUBSTITUTED 2-IMIDAZOLIDINONE AND 2-IMIDAZOLONE AND THEIR USE IN THE TREATMENT OF CANCER
EP2800568A4 (en) COMPOSITIONS, USE METHOD AND TREATMENT METHOD THEREFOR
IL280316B (en) Bolaamphiphilic compounds, compositions and uses thereof
FR2996847B1 (fr) Composes 3,4-bis(catechol)pyrrole-n-substitues, leur preparation et utilisation dans le traitement du cancer
LT2988792T (lt) Farmacinės kompozicijos, turinčios hialurono rūgšties, skirtos naudoti "juodojo disko" ligos (tarpslankstelinio disko degeneracijos) gydymui
FR2986231B1 (fr) Derives de thiazolidinedione, leur preparation et leur utilisation dans le traitement des cancers
EP2750691A4 (en) SRPX FOR THE TREATMENT OF CANCER
GB201207064D0 (en) Pharmaceutical compositions comprising 15-hetre and methods of using the same
HUE050771T2 (hu) BTK szubsztituált nikotinimid inhibitorai és készítményeik és alkalmazásuk rák, gyulladás és autoimmun betegség kezelésében

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

ST Notification of lapse

Effective date: 20250605